Copy
                                                                          View this email in your browser                            
                                                                                                                                       
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 668596

ChiLTERN Newsletter 2

April 2017
Welcome to ChiLTERN's second newsletter, a monthly publication sent to the whole Project network. This is aimed at keeping everyone updated with the progress of the Project. With over 20 collaborators across the United Kingdom, Belgium, Spain, Italy, Switzerland, Germany, Poland, France, Norway, Sweden, Ireland and the Czech Republic, our comprehensive research programme is connected to the single largest clinical trial ever to be undertaken amongst the liver cancer paediatric population. Ultimately, ChiLTERN will aim to cure more children with liver cancer, expose fewer children to toxic chemotherapy and ensure their surgery is both effective and safe.
ChiLTERN at SIOPEL Spring Meeting 2017
The SIOPEL Spring Meeting took place from 6th – 8th April 2017 and it was great to see so many ChiLTERN participants there! During the three-day event, international colleagues took advantage of being together in the same location; to share updates and discuss plans for the future.

Representatives involved in work package 3 met to discuss work flow, CRFs and CINECA’s remote data capture system.  The meeting provided an excellent opportunity to meet in person and further develop the database for PHITT trial data collection and biology sample tracking.

Steven Warmann held a meeting with the radiology review team to discuss the Surgery review project (work package 5). 

ChiLTERN’s Internal Project Board met for the second time, providing an excellent opportunity to update on work package activities, project management and to make contractual decisions.

Bruce Morland, PHITT’s Chief Investigator and lead for work package 2 delivered a buoyant presentation to an audience of over 100 clinicians, investigators and scientists. With many ChiLTERN participants in attendance, an update on PHITT was important for those keen to get the trial open in their country. Bruce’s presentation can be found on the ChiLTERN website.
 
A ChiLTERN update was presented by Project Coordinator and WP1/WP7 lead Keith Wheatley. He focused on tasks completed in these two work packages and key activities in the forthcoming months. Communication of EU-funded projects is both a contractual obligation and is strongly encouraged by the European Commission so Keith took the opportunity to promote ChiLTERN’s new Twitter hashtag @chilterncollab with a QR code to boost the number of followers.  Keith’s presentation can be found on the ChiLTERN website
PHITT Update
Some good news….PHITT now has both ethics and regulatory authority approval in the UK so is ready to go!

The UK approvals allow all NCCs to prepare and submit applications in their countries, and we encourage a quick turnaround time. The trial team at CRCTU are ready to help with any queries, so get in touch using the trial email phitt@trials.bham.ac.uk.

Sites around the UK are currently receiving authorisation to open to recruitment. The first UK site is expected to be open to recruitment in May 2017.
Dates for the diary
  • There will be a full ChiLTERN meeting in the Autumn in Brussels. The date is to be decided and information will be posted in the Meetings section of the project website.  
  • The EU Reporting Period 1 ends on 30th June 2017. 
If you have any news that you would like to be included in the next ChiLTERN newsletter, please get in touch with Louise Woodall by email at chiltern@contacts.bham.ac.uk by Friday 19th May 2017.






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
University of Birmingham · University of Birmingham · Birmingham, West Midlands B15 2TT · United Kingdom

Email Marketing Powered by Mailchimp